UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition Triolif-Mint-Lozenge-SE-AJ-MPD
identifier: http://ema.europa.eu/fhir/mpId
/SE-xxxxxxxxx-00049612, http://ema.europa.eu/fhir/eurdId
/206
domain: Human use
status: Current
combinedPharmaceuticalDoseForm: Lozenge
indication:
Symptomlindring vid halsont hos vuxna och ungdomar över 12 år
legalStatusOfSupply: Medicinal product not subject to medical prescription
classification: various
name
productName: Triolif Mint Sugtablett
part
part: Triolif
type: Invented Name Part
part
part: Mint
type: Flavour part
part
part: Sugtablett
type: Pharmaceutical dose form part
Usages
Country Language Kingdom of Sweden Swedish